The Therapeutic Loop: Closed-Loop Epilepsy Systems Mirroring the Read–Write Architecture of Brain–Computer Interfaces
Source abstract
Abstract
Drug-resistant epilepsy (DRE) remains a major therapeutic challenge, as a considerable proportion of epilepsy patients fail to achieve seizure control with conventional anti-seizure medications or surgical therapy. Closed-loop systems have emerged as a promising alternative, offering patient-specific, on-demand neuromodulation. Despite notable advances in the academic domain, clinical translation has stagnated, and surgical resection remains the intervention with the highest probability of achieving seizure freedom. In this review, we delineate the principal limitations currently constraining progress in epilepsy neuromodulation and conceptualise these systems as instantiations of the read-write architecture characteristic of brain–computer interfaces. The read component entails the continuous acquisition and analysis of neurophysiological signals to predict or detect imminent seizures. In contrast, the write component involves the delivery of targeted interventions to disrupt epileptiform dynamics and prevent clinical seizure manifestation. We outline the closed-loop processing pipeline, survey the current state of the art, and discuss key methodological and translational challenges, particularly in algorithm validation and long-term reliability. Finally, we address patients’ and caregivers’ perspectives on the acceptance and practical integration of such technologies. This work synthesises current advances in the field and delineates the path toward fully autonomous clinically effective closed-loop neuromodulation as a viable treatment paradigm for DRE, aiming to improve patients’ quality of life.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Neurological disorders and treatments · EEG and Brain-Computer Interfaces · Neuroscience and Neural Engineering
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Engineering, Universitat Pompeu Fabra (UPF), 08003 Barcelona, Spain
Epilepsy Group, Hospital del Mar Research Institute (IMIM), 08003 Barcelona, Spain
Funding
Agència de Gestió d’Ajuts Universitaris i de Recerca (AGAUR) Generalitat de Catalunya
References (100+)
Show source-provided references
1. World Health Organization (WHO), International League Against Epilepsy (ILAE), and International Bureau for Epilepsy (IBE) (2019). EPILEPSY: A Public Health Imperative, WHO.
2. Drug resistance in epilepsy10.1016/S1474-4422(23)00151-5 ↗
3. Ni, X.J., Zhong, H., Liu, Y.X., Lin, H.W., and Gu, Z.C. (2022). Current trends and hotspots in drug-resistant epilepsy research: Insights from a bibliometric analysis. Front. Neurol., 13.10.3389/fneur.2022.1023832 ↗
4. Prevalence and risk factors associated with drug-resistant epilepsy in adult epileptic patients10.1186/s41983-023-00750-3 ↗
5. Drug resistance in epilepsy: Clinical impact, potential mechanisms, and new innovative treatment options10.1124/pr.120.019539 ↗
6. Drug-resistant epilepsy and mortality—Why and when do neuromodulation and epilepsy surgery reduce overall mortality10.1111/epi.17413 ↗
7. The burden of chronic drug-refractory focal onset epilepsy: Can it be prevented?10.1016/j.yebeh.2023.109435 ↗
8. Drug resistance predictive utility of age of onset and cortical imaging abnormalities in epilepsy: A systematic review and meta-analysis10.1186/s41983-023-00786-5 ↗
9. Etiological analysis of 167 cases of drug-resistant epilepsy in children10.1186/s13052-024-01619-8 ↗
10. The neurophysiology and seizure outcomes of late onset unexplained epilepsy10.1016/j.clinph.2020.08.014 ↗
11. The aging brain and late onset drug-refractory epilepsies10.1016/j.seizure.2024.08.021 ↗
12. Incidence and prevalence of Drug-Resistant Epilepsy10.1212/WNL.0000000000011839 ↗
13. Clinical Management of Drug Resistant Epilepsy: A review on current strategies10.2147/NDT.S256699 ↗
14. Neuropathological spectrum of drug resistant epilepsy: 15-years-experience from a tertiary care centre10.1016/j.jocn.2021.07.014 ↗
15. The Economic and societal burden associated with drug-resistant epilepsy in the Netherlands: An AIM@EPILEPSY burden-of-disease study protocol10.1136/bmjopen-2024-095123 ↗
16. Perrone, V., Veronesi, C., Cappuccilli, M., Andretta, M., Bacca, M., Barbieri, A., Bartolini, F., Brega, A., Cillo, M.R., and Colasuonno, F. (2025). Characteristics, therapeutic pathway and the economic burden of patients with drug-resistant epilepsy: A real-world analysis following the introduction of cenobamate in Italy. Epilepsia.10.1111/epi.18673 ↗
17. Psychiatric comorbidities in people with epilepsy
18. Malik, N.I., Fatima, R., Ullah, I., Atta, M., Awan, A., Nashwan, A.J., and Ahmed, S. (2022). Perceived stigma, discrimination and psychological problems among patients with epilepsy. Front. Psychiatry, 13.10.3389/fpsyt.2022.1000870 ↗
19. Stigma and psychosocial problems in patients with epilepsy10.37349/en.2023.00026 ↗
20. Arai, Y., Okanishi, T., Noma, H., Kanai, S., Kawaguchi, T., Sunada, H., Fujimoto, A., and Maegaki, Y. (2023). Prognostic factors for employment outcomes in patients with a history of childhood-onset drug-resistant epilepsy. Front. Pediatr., 11.10.3389/fped.2023.1173126 ↗
21. Burden and Its Predictors among Caregivers of Patient with Epilepsy10.14581/jer.20005 ↗
22. Caregiving burden for adults with epilepsy and coping strategies, a systematic review10.1016/j.yebeh.2025.110262 ↗
23. Caregiver burden and healthcare providers perspectives in epilepsy: An observational study in China, Taiwan, and Argentina10.1016/j.ebr.2024.100736 ↗
24. Yu, Z., Shao, Q., Hou, K., Wang, Y., and Sun, X. (2022). The experiences of caregivers of children with epilepsy: A meta-synthesis of qualitative research studies. Front. Psychiatry, 13.10.3389/fpsyt.2022.987892 ↗
25. Seizure burden in severe early-life epilepsy: Perspectives from parents10.1002/epi4.12319 ↗
26. The burden of epilepsy and unmet need in people with focal seizures10.1002/brb3.2589 ↗
27. Clinical and economic implications of epilepsy management across treatment lines in Spain: A real-life database analysis10.1007/s00415-023-11958-x ↗
28. Costs of Epilepsy in Austria: Unemployment as a primary driving factor10.1016/j.seizure.2021.04.020 ↗
29. Outlines to Initiate Epilepsy Surgery in Low- and Middle-Income Countries10.31083/j.jin2105134 ↗
30. A comprehensive review of recent trends in surgical approaches for epilepsy management
31. Gonzalez-Martinez, J.A. (2025). Epilepsy surgery in the last 10 years: Advancements and controversies. Epiliepsy Curr./Epilepsy Curr., 15357597251344166.10.1177/15357597251344166 ↗
32. Current state of the art of traditional and minimal invasive epilepsy surgery approaches10.1016/j.bas.2024.102755 ↗
33. The epileptogenic network concept: Applications in the SEEG exploration of lesional focal epilepsies10.1016/j.neucli.2024.103023 ↗
34. Multilayer brain networks can identify the epileptogenic zone and seizure dynamics10.7554/eLife.68531 ↗
35. Effective connectivity predicts surgical outcomes in temporal lobe epilepsy: A SEEG study10.1111/cns.70563 ↗
36. Outcomes of resective surgery in pediatric patients with drug-resistant epilepsy: A single-center study from the Eastern Mediterranean Region10.1002/epi4.12761 ↗
37. Rates and predictors of seizure freedom in resective epilepsy surgery: An update10.1007/s10143-014-0527-9 ↗
38. Resective Epilepsy Surgery for Drug-Resistant Focal Epilepsy10.1001/jama.2014.17426 ↗
39. Predictors of seizure outcome following resective surgery for drug-resistant epilepsy associated with focal gliosis10.3171/2018.3.JNS172949 ↗
40. Ghosh, S., Sinha, J.K., Ghosh, S., Sharma, H., Bhaskar, R., and Narayanan, K.B. (2023). A comprehensive review of emerging trends and innovative therapies in epilepsy management. Brain Sci., 13.10.3390/brainsci13091305 ↗
41. Role of Responsive Neurostimulation in Managing Drug-Resistant Epilepsy: A Systematic Review of Clinical outcomes
42. Zhang, X., Zhang, X., Huang, Q., and Chen, F. (2024). A review of epilepsy detection and prediction methods based on EEG signal processing and deep learning. Front. Neurosci., 18.10.3389/fnins.2024.1468967 ↗
43. Brain stimulation treatments in epilepsy: Basic mechanisms and clinical advances10.1016/j.bj.2021.08.010 ↗
44. Long-term treatment with responsive brain stimulation in adults with refractory partial seizures10.1212/WNL.0000000000001280 ↗
45. Vagus-nerve stimulation for the treatment of epilepsy10.1016/S1474-4422(02)00220-X ↗
46. Clinical outcomes of VNS therapy with AspireSR® (including cardiac-based seizure detection) at a large complex epilepsy and surgery centre10.1016/j.seizure.2018.03.022 ↗
47. Zangiabadi, N., Ladino, L.D., Sina, F., Orozco-Hernández, J.P., Carter, A., and Téllez-Zenteno, J.F. (2019). Deep Brain Stimulation and Drug-Resistant Epilepsy: A Review of the literature. Front. Neurol., 10.10.3389/fneur.2019.00601 ↗
48. Closed-Loop brain stimulation and paradigm shifts in epilepsy surgery10.1016/j.ncl.2021.12.002 ↗
49. Focal cortex stimulation with a novel implantable device and antiseizure outcomes in 2 prospective multicenter Single-Arm trials10.1001/jamaneurol.2023.0066 ↗
50. Closed-loop vagal nerve stimulation for intractable epilepsy: A single-center experience10.1016/j.seizure.2021.03.030 ↗
51. Fisher, B., DesMarteau, J.A., Koontz, E.H., Wilks, S.J., and Melamed, S.E. (2021). Responsive vagus Nerve Stimulation for Drug Resistant epilepsy: A review of new features and practical guidance for advanced practice providers. Front. Neurol., 11.10.3389/fneur.2020.610379 ↗
52. Seizure detection, seizure prediction, and closed-loop warning systems in epilepsy10.1016/j.yebeh.2014.06.023 ↗
53. Li, Y., Xu, S., Wang, Y., Duan, Y., Jia, Q., Xie, J., Yang, X., Wang, Y., Dai, Y., and Yang, G. (2022). Wireless Closed-Loop Optical regulation system for seizure detection and suppression in vivo. Front. Nanotechnol., 4.10.3389/fnano.2022.829751 ↗
54. Closed-Loop Brain Stimulation for Drug-Resistant Epilepsy: Towards an Evidence-Based Approach to Personalized Medicine10.1007/s13311-018-00682-4 ↗
55. Deep Brain Stimulation Therapy for Drug-Resistant Epilepsy: Present and Future Perspectives10.14581/jer.25004 ↗
56. Advancements in Surgical Therapies for Drug-Resistant Epilepsy: A Paradigm Shift towards Precision Care10.1007/s40120-025-00710-4 ↗
57. Neurostimulation as a promising epilepsy therapy10.1002/epi4.12070 ↗
58. Closed-loop optimization of transcranial magnetic stimulation with electroencephalography feedback10.1016/j.brs.2022.01.016 ↗
59. A wearable repetitive transcranial magnetic stimulation device10.1038/s41467-025-58095-9 ↗
60. Surface EEG-Transcranial Direct Current Stimulation (TDCS) Closed-Loop System10.1142/S0129065717500265 ↗
61. Association of Closed-Loop brain stimulation neurophysiological features with seizure control among patients with focal epilepsy10.1001/jamaneurol.2019.0658 ↗
62. Afra, P., Adamolekun, B., Aydemir, S., and Watson, G.D.R. (2021). Evolution of the Vagus Nerve Stimulation (VNS) therapy System Technology for Drug-Resistant Epilepsy. Front. Med. Technol., 3.10.3389/fmedt.2021.696543 ↗
63. Implantation of a new Vagus Nerve Stimulation (VNS) Therapy® generator, AspireSR®: Considerations and recommendations during implantation and replacement surgery—Comparison to a traditional system10.1007/s00701-015-2362-3 ↗
64. U.S. Food and Drug Administration (2025, December 09). Premarket Approval (PMA)—P970003, Available online: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpma/pma.cfm?id=p970003s173.
65. U.S. Food and Drug Administration (2025, December 09). Premarket Approval (PMA)—P970003, Available online: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfres/res.cfm?id=212010#:~:text=The%20physician%20uses%20the%20programming,Vagus%20Nerve%20Stimulation%20(VNS).
66. U.S. Food and Drug Administration (2025, October 14). Premarket Approval (PMA)—P960009S219, Available online: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpma/pma.cfm?id=p960009s219.
67. U.S. Food and Drug Administration (2025, October 14). Premarket Approval (PMA)—P100026, Available online: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpma/pma.cfm?id=P100026.
68. Randomized controlled trial of trigeminal nerve stimulation for drug-resistant epilepsy10.1212/WNL.0b013e318285c11a ↗
69. Two-year outcomes of epicranial focal cortex stimulation in pharmacoresistant focal epilepsy10.1111/epi.18448 ↗
70. Neuromodulation in epilepsy: State-of-the-art approved therapies10.1016/S1474-4422(21)00300-8 ↗
71. Long-term outcomes after responsive neurostimulation for treatment of refractory epilepsy: A single-center experience of 100 cases10.3171/2023.2.JNS222116 ↗
72. The Efficacy, Safety, and Outcomes of Brain-responsive Neurostimulation (RNS® System) therapy in older adults10.1002/epi4.12541 ↗
73. 271 A retrospective, chart review study of the efficacy and safety of the RNS system in pediatric populations for medically refractory focal epilepsy10.1227/neu.0000000000002809_271 ↗
74. Nine-year prospective efficacy and safety of brain-responsive neurostimulation for focal epilepsy10.1212/WNL.0000000000010154 ↗
75. Real-world experience with direct brain-responsive neurostimulation for focal onset seizures10.1111/epi.16593 ↗
76. Neurostimulation in people with drug-resistant epilepsy: Systematic review and meta-analysis from the ILAE Surgical Therapies Commission10.1111/epi.17243 ↗
77. One-year seizure freedom and quality of life in patients with drug-resistant epilepsy receiving adjunctive vagus nerve stimulation in Japan10.1002/epi4.13025 ↗
78. Vagus nerve stimulation: Outcome and predictors of seizure freedom in long-term follow-up10.1016/j.seizure.2010.03.002 ↗
79. Chen, S., Yang, X., Xu, S., Li, B., Li, C., Yang, N., Yang, X., Wang, X., Xu, S., and Zhao, X. (2025). Long-term outcome of vagus nerve stimulation therapy in drug-resistant epilepsy: A retrospective single-center study. Front. Neurol., 16.10.3389/fneur.2025.1564735 ↗
80. Long-term efficacy and safety of thalamic stimulation for drug-resistant partial epilepsy10.1212/WNL.0000000000001334 ↗
81. Yan, H., Wang, X., Zhang, X., Qiao, L., Gao, R., Ni, D., Shu, W., Xu, C., Ren, L., and Yu, T. (2023). Deep brain stimulation for patients with refractory epilepsy: Nuclei selection and surgical outcome. Front. Neurol., 14.10.3389/fneur.2023.1169105 ↗
82. Electrical stimulation of the anterior nucleus of thalamus for treatment of refractory epilepsy10.1111/j.1528-1167.2010.02536.x ↗
83. The SANTÉ study at 10 years of follow-up: Effectiveness, safety, and sudden unexpected death in epilepsy10.1111/epi.16895 ↗
84. The implantable Neurocybernetic prosthesis system10.1111/j.1540-8159.1991.tb04052.x ↗
85. A rational approach to understanding and evaluating responsive neurostimulation10.1007/s12021-019-09446-7 ↗
86. A prospective, multicenter study of cardiac-based seizure detection to activate vagus nerve stimulation10.1016/j.seizure.2015.08.011 ↗
87. Automatic vagus Nerve stimulation Triggered by Ictal Tachycardia: Clinical Outcomes and Device Performance—The U.S. E-37 Trial10.1111/ner.12376 ↗
88. Kerr, W.T., McFarlane, K.N., and Pucci, G.F. (2024). The present and future of seizure detection, prediction, and forecasting with machine learning, including the future impact on clinical trials. Front. Neurol., 15.10.3389/fneur.2024.1425490 ↗
89. EEG seizure detection: Concepts, techniques, challenges, and future trends10.1007/s11042-023-15052-2 ↗
90. Bai, L., Litscher, G., and Li, X. (2025). Epileptic Seizure Detection Using Machine Learning: A Systematic Review and Meta-Analysis. Brain Sci., 15.10.3390/brainsci15060634 ↗
91. Seizure forecasting: Where do we stand?10.1111/epi.17546 ↗
92. Prediction of seizure likelihood with a long-term, implanted seizure advisory system in patients with drug-resistant epilepsy: A first-in-man study10.1016/S1474-4422(13)70075-9 ↗
93. Epilepsyecosystem.org: Crowd-sourcing reproducible seizure prediction with long-term human intracranial EEG
94. Xu, L., Xu, M., Ke, Y., An, X., Liu, S., and Ming, D. (2020). Cross-Dataset variability problem in EEG decoding with deep learning. Front. Hum. Neurosci., 14.10.3389/fnhum.2020.00103 ↗
95. A large EEG dataset for studying cross-session variability in motor imagery brain–computer interface10.1038/s41597-022-01647-1 ↗
96. Tajadini, B., Seydnejad, S.R., and Rezakhani, S. (2024). Short-term epileptic seizures prediction based on cepstrum analysis and signal morphology. BMC Biomed. Eng., 6.10.1186/s42490-024-00081-1 ↗
97. Śliwowski, M., Martin, M., Souloumiac, A., Blanchart, P., and Aksenova, T. (2023). Impact of dataset size and long-term ECoG-based BCI usage on deep learning decoders performance. Front. Hum. Neurosci., 17.10.3389/fnhum.2023.1111645 ↗
98. Quantity versus Diversity: Influence of Data on Detecting EEG Pathology with Advanced ML Models10.1016/j.neunet.2025.108073 ↗
99. A multi-day and high-quality EEG dataset for motor imagery brain–computer interface10.1038/s41597-025-04826-y ↗
100. Scaling convolutional neural networks achieves expert level seizure detection in neonatal EEG10.1038/s41746-024-01416-x ↗